Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-15.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-15.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202521.54%
202448.89%
202310.64%
2022-2.56%
202135.91%
202049.35%
2019213.45%
20187.29%
2017-18.84%
2016-3.09%